Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

De Novo Biosynthesis of Sakuranetin from Glucose by Engineered Saccharomyces cerevisiae
  • +5
  • Weihong Zhong,
  • Shuai Tu,
  • Feng Xiao,
  • Chengyu Mei,
  • Shuang Li,
  • Pei Qiao,
  • Ziyan Huang,
  • Zhixing Gong
Weihong Zhong
Zhejiang University of Technology

Corresponding Author:[email protected]

Author Profile
Shuai Tu
Zhejiang University of Technology
Author Profile
Feng Xiao
Zhejiang University
Author Profile
Chengyu Mei
Zhejiang University of Technology
Author Profile
Shuang Li
Zhejiang University of Technology
Author Profile
Pei Qiao
Zhejiang University of Technology
Author Profile
Ziyan Huang
Zhejiang University of Technology
Author Profile
Zhixing Gong
Zhejiang University of Technology
Author Profile

Abstract

Sakuranetin is a plant-natural product, which has increasingly been utilized in cosmetic and pharmaceutical industries for its extensive anti-inflammatory, anti-tumor, and immunomodulatory effects. Sakuranetin was mostly produced via extraction technology from plants, which is limited to natural conditions and biomass supply. In this study, a novel strategy to produce sakuranetin via de novo synthesis from glucose by engineering S. cerevisiae was introduced . After a series of heterogenous genes integration, a biosynthetic pathway of sakuranetin from glucose was successfully constructed in S. cerevisiae which sakuranetin yield reached only 4.28 mg/L. Then, a multi-module metabolic engineering strategy was applied for improving sakuranetin yield in S. cerevisiae: (1) adjusting the copy number of sakuranetin synthesis genes; (2) removing the rate-limiting factor of aromatic amino pathway and optimizing the synthetic pathway of aromatic amino acids to enhance the supply of carbon flux for sakuranetin; (3) introducing acetyl-CoA carboxylase mutants ACC1S659A, S1157A, and knocking-out YPL062W to strengthen the supply of malonyl-CoA which is another synthetic precursor of sakuranetin. The resultant mutant S. cerevisiae exhibited a more than 10-fold increase of sakuranetin titer (50.62 mg/L) in shaking flasks. Furthermore, the sakuranetin titer increased to 158.65 mg/L in a 1-L bioreactor, which is the highest sakuranetin titer among all publications reported yield of the engineered microbial cell.